Cost of Lost Productive Work Time among US Workers with Depression

JAMA

Volumn 289, Issue 23, 2003, Pages 3135-3144

  Stewart, Walter F ^a,b   Ricci, Judith A ^a   Chee, Elsbeth ^a   Hahn, Steven R ^c   Morganstein, David ^d  

^a AdvancePCS Ctr for Work and Health   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ABSENTEEISM; ADULT; AGED; ANAMNESIS; ARTICLE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISABILITY; DRUG USE; FEMALE; HUMAN; INCOME; INTERVIEW; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIMARY CARE EVALUATION OF MENTAL DISORDERS MOOD MODULE FOR DEPRESSION; PRIORITY JOURNAL; PRODUCTIVITY; QUESTIONNAIRE; RANDOMIZATION; SCREENING TEST; SELF REPORT; SOMATIC SYMPTOM INVENTORY; UNITED STATES; COST OF ILLNESS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMPLOYMENT; FACTORIAL ANALYSIS; HEALTH SURVEY; MIDDLE AGED; STATISTICAL MODEL; STATISTICS;

ADULT; COST OF ILLNESS; DEPRESSION; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EFFICIENCY; EMPLOYMENT; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; UNITED STATES;

EID: 0037493499     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.23.3135     Document Type: Article

References (61)

1. Dasbach EJ, Carides GW, Gerth WC, Santanello NC, Pigeon JG, Kramer MS. Work and productivity loss in the rizatriptan multiple attack study. Cephalalgia. 2000;20:830-834.
2. Davies GM, Santanello N, Gerth W, Lerner D, Block GA. Validation of a migraine work and productivity loss questionnaire for use in migraine studies. Cephalalgia. 1999;19:497-502.
3. Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics. 2001;19:197-206.
4. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813-818.
5. McCunney RJ. Health and productivity: a role for occupational health professionals. J Occup Environ Med. 2001;43:30-35.
6. Schulman EA, Cady RK, Henry D, et al. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind placebo-controlled clinical trial. Mayo Clin Proc. 2000;75:782-789.
7. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the national health interview survey. Headache. 1993;33:29-35.
8. Stang P, Cady R, Batenhorst A, Hoffman L. Workplace productivity: a review of the impact of migraine and its treatment. Pharmacoeconomics. 2001;19:231-244.
9. Fautrel B, Guillemin F. Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol. 2002;14:121-126.
10. Riedel JE, Baase C, Hymel P, Lynch W, Dreisbach S, Peterson KW. Preventing Disease and Promoting Health: Impact on Productivity, Scottsdale, Ariz: Institute for Health and Productivity Management; 2001.
11. Burton WN, Connerty CM. Evaluation of a worksite-based patient education intervention targeted at employees with diabetes mellitus. J Occup Environ Med. 1998;40:702-706.
12. Ng YC, Jacobs P, Johnson JA. Productivity losses associated with diabetes in the US. Diabetes Care. 2001;24:257-261.
13. Blaiss MS. Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc. 2000;21:7-13.
14. Blanc PD, Trupin L, Eisner L, et al. The work impact of asthma and rhinitis; findings from a population-based survey. J Clin Epidemiol. 2001;54:610-618.
15. Burton WN, Conti DJ, Chen C-Y, Schultz AB, Edington DW. The impact of allergies and allergy treatment on worker productivity. J Occup Environ Med. 2001;43:64-71.
16. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manage Care. 2000;6:373-378.
17. Kessler RC, Almeida DM, Berglund P, Stang P. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87:289-295.
18. Slavin RG. Occupational and allergic rhinitis: impact on worker productivity and safety. Allergy Asthma Proc. 1998;19:277-284.
19. Borchardt PJ. Employee productivity and gastroesophageal reflux disease: the payer's viewpoint. Am J Gastroenterol. 2001;96(suppl 8):S62-S63.
20. Henke CJ, Levin TR, Henning JM, Potter LP. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000;95:788-792.
21. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol. 2001;96 (suppl 8):S57-S61.
22. Berndt ER, Bailit HL, Keller MB, Verner JC, Finkelstein SN. Health care use and at-work productivity among employees with mental disorders. Health Aff (Millwood). 2000;19(4):244-256.
23. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-418.
24. Simon GE, Revicki D, Heiligenstein J, et al. Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry. 2000;22;153-162.
25. Simon GE, Barber C, Birnbaum HG, et al. Depression and work productivity: the comparative costs of treatment versus nontreatment. J Occup Environ Med. 2001;43:2-9.
26. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA. 2002;287:203-209,
27. Ricci JA, Stewart WF, Leotta C, Chee E. A comparison of six phone interviews designed to measure health-related lost productive work time. Value Health. 2001;4:460.
28. Karasek R, Gordon G, Pietrokovsky C, Frese M, Pieper C. Job Content Instrument: Questionnaire and User's Guide, Version 1. 1. Los Angeles: University of Southern California; 1986.
29. Bureau of Labor Statistics, Bureau of the Census. Current Population Survey. Available at: http://www.bls.census.gov/cps/cpsmain.htm. Accessibility verified May 19, 2003.
30. Brick JM, Kalton G. Handling missing data in survey research. Stat Methods Med Res. 1996;5:215-238.
31. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749-1756.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
33. Barsky AG, Wyshak G, Herman GL. Hypochondriasis: an evaluation of the DSM-III criteria in medical outpatients. Arch Gen Psychiatry. 1986;43:493-500.
34. Murray CJL, Lopez AD, eds. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass: Harvard University Press; 1996.
35. Stoudemire A, Frank R, Hedemark N, Kamlet M, Blazer D. The economic burden of depression. Gen Hosp Psychiatry. 1986;8:387-394.
36. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA. 1990;264:2524-2550.
37. Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA. 1992;267:1478-1483.
38. Conti DJ, Burton WN. The economic impact of depression in a workplace. J Occup Med. 1994;36:983-988.
39. Judd FK, Mijch AM. Depressive symptoms in patients with HIV Infection. Aust N Z J Psychiatry. 1996;30:104-109.
40. Finkelstein SN, Berndt ER, Greenberg PE, Parsley RA, Russell JM, Keller MB, Chronic Depression Study Group. Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Psychopharmacol Bull. 1996;32:33-40.
41. Zhang M, Rost KM, Fortney JC, Smith GR. A community study of depression treatment and employment earnings. Psychiatric Services. 1999;50:1209-1213.
42. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "Top 10" physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45:5-14.
43. Eaton WW, Anthony JC, Mandel W, Garrison R. Occupations and the prevalence of major depressive disorder. J Occup Med. 1990;32:1079-1087.
44. Goff VV. Depression: A Decade of Progress, More to Do. Washington, DC: National Health Policy Forum; November 22, 2002. Issue brief 786.
45. Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey 1987. National Center for Health Statistics, Vital Health Stat 13.1989;100:1-304.
46. Kozak LJ, Hall MJ, Owings MF. National Hospital Discharge Survey: 2000 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2002;153:1-194.
47. Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. When antihistamines go to work. Bus Health. 1999;17:49-50.
48. Cull RE, Wells NEJ, Miocevich ML. The economic cost of migraine. Br J Med Econ. 1992;2:103-115.
49. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff (Millwood). 1999;18(5):163-171.
50. Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum. 2001;44:528-534.
51. Osterhaus JT, Guterman DL, Piachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992;2:67-76.
52. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorder in the United States. Arch Gen Psychiatry. 1994;51:8-19.
53. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992;49:809-816.
54. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale to consensus definitions of terms in major depressive disorders: response, remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48:851-855.
55. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026-1031.
56. Schulberg HC, Block MR, Madonia MJ, et al. Treating major depression in primary care practice: eight-month clinical outcomes. Arch Gen Psychiatry. 1996;53:913-919.
57. Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 1993;150:734-741.
58. Stahl SM. Does depression hurt? J Clin Psychiatry. 2002;63:273-274.
59. Parsons T. The Social System. New York, NY: The Free Press; 1950.
60. Berger ML, Murray JF, Xu J, Pauly M. Alternative valuations of work loss and productivity. J Occup Environ Med. 2001;43:18-24.
61. Morgado A, Raoux N, Smith M, Allilaire JF, Widlocher D. Subjective bias in reports of poor work adjustment in depressed patients. Acta Psychiatr Scand. 1989;80:541-547.